pimozide has been researched along with Carcinoma, Pancreatic Ductal in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auld, D; Bauer, AS; Büchler, MW; Costello, E; Fassan, M; Giese, NA; Greenhalf, W; Hackert, T; Hall, A; Hoheisel, JD; Huang, S; Jandaghi, P; Lathrop, M; Monast, A; Najafabadi, HS; Neoptolemos, JP; Papadakis, AI; Park, M; Riazalhosseini, Y; Sangwan, V; Scarpa, A; Sipos, B; Strobel, O; von Knebel Doeberitz, M; Zogopoulos, G | 1 |
1 other study(ies) available for pimozide and Carcinoma, Pancreatic Ductal
| Article | Year |
|---|---|
Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice.
Topics: Adult; Aged; Aged, 80 and over; Animals; Apoptosis; Carcinoma, Pancreatic Ductal; Case-Control Studies; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dopamine D2 Receptor Antagonists; eIF-2 Kinase; Endoplasmic Reticulum Stress; Female; Gene Knockdown Techniques; Haloperidol; Humans; Male; Mice; Middle Aged; Pancreatic Neoplasms; Phosphorylation; Pimozide; Receptors, Dopamine D2; RNA, Small Interfering; Signal Transduction; Transcriptome; Unfolded Protein Response; Up-Regulation | 2016 |